Medicine
Levophed 4 mg/4 mL injection
Levophed 4 mg/4 mL injection is a prescription medicine containing Norepinephrine for intravenous use, marketed by Hospira, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Norepinephrine
- Brand
- Levophed
- Strength
- 4 mg/4 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 4 mL
- Marketing authorisation holder
- Hospira
- Manufacturer
- Hospira
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store in original carton until time of administration to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CA03 Norepinephrine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 April 2009
- Identifiers
- RxCUI 209217, 242969DailyMed set ID c4de72a8-2a75-4984-ce90-e4870226dc12, 2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10NDC 0409-3375, 0409-0161Application NDA007513
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 13 July 1950 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Norepinephrine 4 mg/4 mL injection.
Other strengths and forms of Norepinephrine
Clinical summary
Norepinephrine is a catecholamine indicated to raise blood pressure in adult patients with severe, acute hypotension. It is available as injection for intravenous use. MedsAcross supplies Norepinephrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NorepinephrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LEVOPHED prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Levophed 4 mg/4 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.